Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Hatzl S, Posch F, Rezai A, Gornicec M, Beham-Schmid C, Magnes T, Wangner S, Deutsch A, Greinix H, Uhl B, Prochazka KT, Egle A, Greil R, Melchardt T, Linkesch W, Schulz E, Neumeister P. Hatzl S, et al. Among authors: posch f. Support Care Cancer. 2021 Sep;29(9):5197-5207. doi: 10.1007/s00520-021-06059-2. Epub 2021 Feb 24. Support Care Cancer. 2021. PMID: 33625586 Free PMC article.
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka KT, Melchardt T, Posch F, Schlick K, Deutsch A, Beham-Schmid C, Weiss L, Gary T, Neureiter D, Klieser E, Greil R, Neumeister P, Egle A, Pichler M. Prochazka KT, et al. Among authors: posch f. Br J Cancer. 2016 Nov 8;115(10):1264-1272. doi: 10.1038/bjc.2016.325. Epub 2016 Oct 20. Br J Cancer. 2016. PMID: 27764838 Free PMC article.
Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Prochazka KT, Posch F, Deutsch A, Beham-Schmid C, Stöger H, Abdyli L, Greinix H, Pichler M, Neumeister P. Prochazka KT, et al. Among authors: posch f. Br J Haematol. 2018 Oct;183(1):142-146. doi: 10.1111/bjh.14912. Epub 2017 Sep 6. Br J Haematol. 2018. PMID: 28875547 Free article. No abstract available.
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Hatzl S, Posch F, Schulz E, Gornicec M, Deutsch A, Beham-Schmid C, Pichler M, Greinix H, Sill H, Zebisch A, Neumeister P, Prochazka KT. Hatzl S, et al. Among authors: posch f. Pathol Oncol Res. 2020 Oct;26(4):2831-2833. doi: 10.1007/s12253-020-00864-6. Epub 2020 Jun 29. Pathol Oncol Res. 2020. PMID: 32602002 Free article. No abstract available.
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Riedl JM, Posch F, Horvath L, Gantschnigg A, Renneberg F, Schwarzenbacher E, Moik F, Barth DA, Rossmann CH, Stotz M, Schaberl-Moser R, Pichler M, Stöger H, Greil R, Djanani A, Schlick K, Gerger A. Riedl JM, et al. Among authors: posch f. Eur J Cancer. 2021 Jul;151:3-13. doi: 10.1016/j.ejca.2021.03.040. Epub 2021 May 2. Eur J Cancer. 2021. PMID: 33951545 Free article.
Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Hatzl S, Posch F, Sareban N, Stradner M, Rosskopf K, Reisinger AC, Eller P, Schörghuber M, Toller W, Sloup Z, Prüller F, Gütl K, Pilz S, Rosenkranz AR, Greinix HT, Krause R, Schlenke P, Schilcher G. Hatzl S, et al. Among authors: posch f. Ann Intensive Care. 2021 May 12;11(1):73. doi: 10.1186/s13613-021-00867-9. Ann Intensive Care. 2021. PMID: 33978844 Free PMC article.
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Riedl JM, Schwarzenbacher E, Moik F, Horvath L, Gantschnigg A, Renneberg F, Posch F, Barth DA, Stotz M, Pichler M, Hatzl S, Fandler-Höfler S, Gressenberger P, Gary T, Jost PJ, Greil R, Ay C, Djanani A, Gerger A, Schlick K. Riedl JM, et al. Among authors: posch f. Thromb Haemost. 2022 Apr;122(4):633-645. doi: 10.1055/a-1548-4847. Epub 2021 Aug 24. Thromb Haemost. 2022. PMID: 34255340
132 results